Characteristics of lymphocyte populations and macrophages of the lamina propria in chronic inflammatory bowel disease. the role of cytokines
Gayá, A.
Gastroenterologia y Hepatologia 18(10): 510-514
1995
ISSN/ISBN: 0210-5705 PMID: 8548587 Document Number: 446581
Document emailed within 1 workday
Related Documents
Yuan, S.Z.; Foster, L.P.; Wang, N.S.; Kraft, S.C. 1992: Investigation on lymphocyte subpopulations in the intestinal lamina propria in inflammatory bowel diseases Chinese Medical Journal 105(1): 18-24Lügering, N.; Kucharzik, T.; Stoll, R.; Domschke, W. 1998: Current concept of the role of monocytes/macrophages in inflammatory bowel disease--balance of proinflammatory and immunosuppressive mediators Italian Journal of Gastroenterology and Hepatology 30(3): 338-344
Pozsonyi, T.; Fehér, J.; Jakab, L. 1981: Lymphocyte populations in chronic active liver disease: in vitro effect of levamisole on T-lymphocyte populations Allergologia et Immunopathologia 9(1): 37-44
Kmieć, Z. 1998: Cytokines in inflammatory bowel disease Archivum Immunologiae et Therapiae Experimentalis 46(3): 143-155
Kolacek, S. 2002: Role of enteral nutrition in the treatment of chronic inflammatory bowel disease Medicinski Arhiv 56(1 Suppl 1: 21-22
Quah, S.H. 2013: Role of probiotics and nutrition in the management of chronic inflammatory bowel disease in children Singapore Medical Journal 54(4): 183-184
Fernández-Bañares, F. 1995: Role of reactive oxygen metabolites in the pathogenesis of chronic inflammatory bowel disease Gastroenterologia y Hepatologia 18(10): 526-536
Nishida, Y.; Murase, K.; Isomoto, H.; Furusu, H.; Mizuta, Y.; Riddell, R.H.; Kohno, S. 2002: Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease Hepato-Gastroenterology 49(45): 678-682
Arai, K. 2012: Diagnosis and clinical characteristics of pediatric inflammatory bowel disease Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 482-490
Moulton, P.J. 1996: Inflammatory joint disease: the role of cytokines, cyclooxygenases and reactive oxygen species British Journal of Biomedical Science 53(4): 317-324
Morelli, M.S.; Zucker, S.D. 2003: A role for the appendix in inflammatory bowel disease? Cut it out Gastroenterology 125(4): 1270-2; Discussion 1272
Asigbetse, K.E.; Eigenmann, P.A.; Frossard, C.P. 2010: Intestinal lamina propria TcRgammadelta+ lymphocytes selectively express IL-10 and IL-17 Journal of Investigational Allergology and Clinical Immunology 20(5): 391-401
Carinelli, G.S.; Bruni, M.; Senzani, F.M.; Rainoldi, R.; Remotti, G. 1979: The elastic structure off the lamina propria of the lower third of the vagina after irradiation Annali di Ostetricia Ginecologia Medicina Perinatale 100(6): 399-403
Martin, J.C.; Le Bouffant, L.; Normand, C.; Lustenberger, L. 1974: Infrastructural study of the/bronchial lamina propria and lymphoid structures Les Bronches 24(3): 145-150
Rerknimitr, R.; Chalapipat, O.; Kongkam, P.; Mb, P.K. 2005: Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review Journal of the Medical Association of Thailand 88(Suppl 4): S129-S133
Guerra Montero, L.Justino.; Ingver, A.; Casañas, A.; Sosa, C.; Iade, B. 2010: Clinical characteristics of patients with inflammatory bowel disease and thromboembolic events Acta Gastroenterologica Latinoamericana 40(2): 134-141
Tsai, C-Hsien.; Chen, H-Ling.; Ni, Y-Hsuan.; Hsu, H-Yuan.; Jeng, Y-Ming.; Chang, C-Jeng.; Chang, M-Hwei. 2004: Characteristics and trends in incidence of inflammatory bowel disease in Taiwanese children Journal of the Formosan Medical Association 103(9): 685-691
Ashida, T. 2008: Inflammatory bowel disease--the role and issue of glucocorticoid Nihon Rinsho. Japanese Journal of Clinical Medicine 66(1): 137-141
Nielsen, S.E.øe.; Nielsen, O.H.; Vainer, B.; Claesson, M.H. 2002: Inflammatory bowel disease--do microorganisms play a role? Ugeskrift for Laeger 164(50): 5947-5950
Seegert, D.; Schreiber, S. 2002: Overview: interleukin-16 and its role in inflammatory bowel disease Current Opinion in Investigational Drugs 3(4): 562-564